GRAPL
gene geneOn this page
Summary
GRAPL (GRB2 related adaptor protein like, HGNC:37240) is a protein-coding gene on chromosome 17p11.2, encoding GRB2-related adapter protein-like (Q8TC17).
Predicted to enable receptor tyrosine kinase binding activity and signaling adaptor activity. Predicted to be involved in cell migration and enzyme-linked receptor protein signaling pathway. Predicted to be located in cytosol. Predicted to be active in cytoplasm.
Source: NCBI Gene 400581 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 3 total
- MANE Select transcript:
NM_001129778
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:37240 |
| Approved symbol | GRAPL |
| Name | GRB2 related adaptor protein like |
| Location | 17p11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000189152 |
| Ensembl biotype | protein_coding |
| Entrez | 400581 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 4 protein_coding, 1 nonsense_mediated_decay
ENST00000344415, ENST00000437957, ENST00000574324, ENST00000577213, ENST00000583540
RefSeq mRNA: 2 — MANE Select: NM_001129778
NM_001129778, NM_001353418
CCDS: CCDS45627
Canonical transcript exons
ENST00000344415 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001536358 | 19158319 | 19159187 |
| ENSE00002259270 | 19127589 | 19127697 |
| ENSE00003543839 | 19132642 | 19132739 |
| ENSE00003787618 | 19138466 | 19138588 |
Expression profiles
Bgee: expression breadth ubiquitous, 153 present calls, max score 85.98.
FANTOM5 (CAGE): breadth broad, TPM avg 0.4427 / max 13.3248, expressed in 216 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 159828 | 0.4427 | 216 |
Top tissues by expression
242 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| spleen | UBERON:0002106 | 85.98 | gold quality |
| vermiform appendix | UBERON:0001154 | 85.11 | gold quality |
| lymph node | UBERON:0000029 | 80.59 | gold quality |
| granulocyte | CL:0000094 | 77.26 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 75.56 | gold quality |
| caecum | UBERON:0001153 | 75.54 | gold quality |
| gall bladder | UBERON:0002110 | 72.69 | gold quality |
| right uterine tube | UBERON:0001302 | 72.12 | gold quality |
| small intestine | UBERON:0002108 | 71.85 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 71.65 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 71.36 | gold quality |
| colonic epithelium | UBERON:0000397 | 70.68 | gold quality |
| metanephros cortex | UBERON:0010533 | 70.66 | gold quality |
| leukocyte | CL:0000738 | 70.38 | gold quality |
| monocyte | CL:0000576 | 70.13 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 69.94 | gold quality |
| bone marrow cell | CL:0002092 | 69.66 | silver quality |
| upper lobe of lung | UBERON:0008948 | 69.59 | gold quality |
| right lung | UBERON:0002167 | 69.51 | gold quality |
| right adrenal gland | UBERON:0001233 | 68.13 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 68.01 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 67.92 | gold quality |
| omental fat pad | UBERON:0010414 | 67.81 | gold quality |
| peritoneum | UBERON:0002358 | 67.74 | gold quality |
| thyroid gland | UBERON:0002046 | 67.46 | gold quality |
| tonsil | UBERON:0002372 | 67.40 | gold quality |
| blood | UBERON:0000178 | 67.20 | gold quality |
| mucosa of stomach | UBERON:0001199 | 67.20 | gold quality |
| left adrenal gland | UBERON:0001234 | 67.18 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 67.05 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.56 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
15 targeting GRAPL, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-302E | 99.96 | 70.74 | 2669 |
| HSA-MIR-642A-5P | 99.51 | 65.10 | 1152 |
| HSA-MIR-6852-5P | 99.17 | 66.69 | 2073 |
| HSA-MIR-661 | 99.09 | 65.94 | 2062 |
| HSA-MIR-3619-5P | 99.00 | 68.87 | 2308 |
| HSA-MIR-1294 | 98.91 | 69.26 | 1030 |
| HSA-MIR-9986 | 98.91 | 69.28 | 1024 |
| HSA-MIR-214-3P | 98.71 | 68.12 | 2128 |
| HSA-MIR-761 | 98.71 | 68.07 | 2051 |
| HSA-MIR-4710 | 98.61 | 65.96 | 1048 |
| HSA-MIR-6881-5P | 98.16 | 67.38 | 665 |
| HSA-MIR-4443 | 98.02 | 66.25 | 1928 |
| HSA-MIR-7855-5P | 97.39 | 67.18 | 925 |
| HSA-MIR-6741-5P | 93.86 | 63.06 | 437 |
| HSA-MIR-615-3P | 90.62 | 68.07 | 69 |
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | grapa | ENSDARG00000005414 |
| danio_rerio | grapb | ENSDARG00000022668 |
| mus_musculus | Grap | ENSMUSG00000004837 |
| rattus_norvegicus | Grap | ENSRNOG00000002599 |
| drosophila_melanogaster | dock | FBGN0010583 |
| caenorhabditis_elegans | WBGENE00006410 |
Paralogs (9): DAPP1 (ENSG00000070190), NCK2 (ENSG00000071051), GRAP2 (ENSG00000100351), SLA2 (ENSG00000101082), GRAP (ENSG00000154016), SLA (ENSG00000155926), NCK1 (ENSG00000158092), GRB2 (ENSG00000177885), SH2D5 (ENSG00000189410)
Protein
Protein identifiers
GRB2-related adapter protein-like — Q8TC17 (reviewed: Q8TC17)
All UniProt accessions (5): I3L2E9, J3QRP9, K7EKU7, K7ELI1, Q8TC17
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the GRB2/sem-5/DRK family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8TC17-1 | 1 | yes |
| Q8TC17-2 | 2 |
RefSeq proteins (2): NP_001123250, NP_001340347 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000980 | SH2 | Domain |
| IPR001452 | SH3_domain | Domain |
| IPR035645 | GRAP_N_SH3 | Domain |
| IPR036028 | SH3-like_dom_sf | Homologous_superfamily |
| IPR036860 | SH2_dom_sf | Homologous_superfamily |
| IPR043539 | Grb2-like | Family |
Pfam: PF00017, PF00018
UniProt features (6 total): domain 2, chain 1, region of interest 1, compositionally biased region 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8TC17-F1 | 86.62 | 0.65 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 18 (showing top):
GOMF_SIGNALING_RECEPTOR_BINDING, GOMF_KINASE_BINDING, GOMF_PROTEIN_TYROSINE_KINASE_BINDING, GOMF_SIGNALING_ADAPTOR_ACTIVITY, GOMF_RECEPTOR_TYROSINE_KINASE_BINDING, GOBP_ENZYME_LINKED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY, MIR6881_5P, GOMF_MOLECULAR_ADAPTOR_ACTIVITY, DESCARTES_MAIN_FETAL_LYMPHATIC_ENDOTHELIAL_CELLS, DESCARTES_FETAL_ADRENAL_VASCULAR_ENDOTHELIAL_CELLS, GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_DN, GOBP_CELL_MOTILITY, HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL, GOBP_CELL_MIGRATION, GSE9960_HEALTHY_VS_SEPSIS_PBMC_DN
GO Biological Process (2): enzyme-linked receptor protein signaling pathway (GO:0007167), cell migration (GO:0016477)
GO Molecular Function (3): receptor tyrosine kinase binding (GO:0030971), signaling adaptor activity (GO:0035591), protein binding (GO:0005515)
GO Cellular Component (2): cytoplasm (GO:0005737), cytosol (GO:0005829)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| cell surface receptor signaling pathway | 1 |
| cell motility | 1 |
| signaling receptor binding | 1 |
| protein tyrosine kinase binding | 1 |
| protein-macromolecule adaptor activity | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| cytoplasm | 1 |
Protein interactions and networks
STRING
514 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GRAPL | LCNL1 | Q6ZST4 | 488 |
| GRAPL | LRRC24 | Q50LG9 | 404 |
| GRAPL | CLEC17A | Q6ZS10 | 386 |
| GRAPL | SACK1G | A6ND36 | 377 |
| GRAPL | CLEC12B | Q2HXU8 | 356 |
| GRAPL | NOC3L | Q8WTT2 | 356 |
| GRAPL | PDILT | Q8N807 | 351 |
| GRAPL | OPN1MW2 | P0DN77 | 350 |
| GRAPL | OPN1LW | P04000 | 350 |
| GRAPL | FCAMR | Q8WWV6 | 342 |
| GRAPL | SLC14A2 | Q15849 | 310 |
| GRAPL | CLNK | Q7Z7G1 | 301 |
| GRAPL | CCNB1IP1 | Q9NPC3 | 301 |
| GRAPL | TDRD6 | O60522 | 298 |
| GRAPL | SH2D2A | Q9NP31 | 293 |
IntAct
14 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF76 | GRAPL | psi-mi:“MI:0915”(physical association) | 0.560 |
| TCP11 | GRAPL | psi-mi:“MI:0915”(physical association) | 0.560 |
| RIPPLY1 | GRAPL | psi-mi:“MI:0915”(physical association) | 0.560 |
| GRAPL | TCP11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRKAB2 | GRAPL | psi-mi:“MI:0915”(physical association) | 0.560 |
| GRAPL | TPGS2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| RIPPLY1 | GRAPL | psi-mi:“MI:0915”(physical association) | 0.000 |
| PRKAB2 | GRAPL | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (6): GRAPL (Two-hybrid), GRAPL (Two-hybrid), GRAPL (Two-hybrid), GRAPL (Two-hybrid), TPGS2 (Affinity Capture-MS), GRAPL (Affinity Capture-RNA)
ESM2 similar proteins: A6QLK6, O14508, O35717, O70277, O75382, O88582, O95057, P09851, P20936, P49138, P50904, P57790, P62993, P62994, P87379, Q05B84, Q07883, Q08012, Q13588, Q14145, Q16644, Q2T9Z7, Q3SYZ2, Q5PR73, Q5R4J7, Q5R6S2, Q5R774, Q5RKN4, Q5ZLD3, Q60631, Q66H84, Q66II3, Q684M4, Q6GPJ9, Q6TDP3, Q6YKA8, Q6ZPT1, Q7YRV6, Q861R0, Q8TC17
Diamond homologs: A0JNB0, A1CEK6, A1DFN5, A1Y2K1, A2QW93, A4IF63, A4RF61, A5D7F8, A5D8S5, A6QLK6, A7A261, B0BNA1, B1V8A0, D2GXS7, D3ZQG6, F1RDG9, F7H9X2, O01498, O08641, O35179, O35180, O35964, O43125, O70277, O75382, P06241, P09769, P0CR79, P13406, P19706, P19878, P27446, P32793, P39688, P43603, P62484, Q08012, Q09822, Q0CJU8, Q0U6X7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
3 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 2 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
805 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:19127683:G:GT | donor_gain | 1.0000 |
| 17:19127694:CAAGG:C | donor_loss | 1.0000 |
| 17:19127696:AGG:A | donor_loss | 1.0000 |
| 17:19127697:GGTA:G | donor_loss | 1.0000 |
| 17:19127698:GT:G | donor_loss | 1.0000 |
| 17:19127699:T:A | donor_loss | 1.0000 |
| 17:19132637:CACA:C | acceptor_loss | 1.0000 |
| 17:19132638:ACAG:A | acceptor_loss | 1.0000 |
| 17:19132639:CA:C | acceptor_loss | 1.0000 |
| 17:19132640:A:AG | acceptor_gain | 1.0000 |
| 17:19132641:G:GA | acceptor_gain | 1.0000 |
| 17:19132641:G:T | acceptor_loss | 1.0000 |
| 17:19132641:GA:G | acceptor_gain | 1.0000 |
| 17:19132641:GATC:G | acceptor_gain | 1.0000 |
| 17:19132740:G:GG | donor_gain | 1.0000 |
| 17:19138549:A:T | donor_gain | 1.0000 |
| 17:19138550:GA:G | donor_gain | 1.0000 |
| 17:19138552:G:GG | donor_gain | 1.0000 |
| 17:19138568:G:GT | donor_gain | 1.0000 |
| 17:19138584:GTGAA:G | donor_gain | 1.0000 |
| 17:19138586:G:GT | donor_gain | 1.0000 |
| 17:19138586:GAA:G | donor_gain | 1.0000 |
| 17:19138589:G:GG | donor_gain | 1.0000 |
| 17:19127698:G:GG | donor_gain | 0.9900 |
| 17:19132633:T:A | acceptor_gain | 0.9900 |
| 17:19132636:CCACA:C | acceptor_loss | 0.9900 |
| 17:19132639:C:G | acceptor_gain | 0.9900 |
| 17:19132641:GAT:G | acceptor_gain | 0.9900 |
| 17:19132641:GATCC:G | acceptor_gain | 0.9900 |
| 17:19132736:ATCC:A | donor_gain | 0.9900 |
AlphaMissense
771 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:19132669:T:A | W36R | 1.000 |
| 17:19132669:T:C | W36R | 1.000 |
| 17:19127644:T:C | F9L | 0.999 |
| 17:19127646:T:A | F9L | 0.999 |
| 17:19127646:T:G | F9L | 0.999 |
| 17:19132671:G:C | W36C | 0.999 |
| 17:19132671:G:T | W36C | 0.999 |
| 17:19132678:G:C | A39P | 0.999 |
| 17:19132679:C:A | A39D | 0.999 |
| 17:19132700:G:A | G46E | 0.999 |
| 17:19132708:C:T | P49S | 0.999 |
| 17:19132709:C:A | P49H | 0.999 |
| 17:19127633:C:A | A5D | 0.998 |
| 17:19127675:T:C | F19S | 0.998 |
| 17:19127693:T:C | L25P | 0.998 |
| 17:19132670:G:C | W36S | 0.998 |
| 17:19132699:G:A | G46R | 0.998 |
| 17:19132699:G:C | G46R | 0.998 |
| 17:19132708:C:A | P49T | 0.998 |
| 17:19138467:T:A | W60R | 0.998 |
| 17:19138467:T:C | W60R | 0.998 |
| 17:19138536:T:C | F83L | 0.998 |
| 17:19138538:C:A | F83L | 0.998 |
| 17:19138538:C:G | F83L | 0.998 |
| 17:19127645:T:C | F9S | 0.997 |
| 17:19127693:T:A | L25H | 0.997 |
| 17:19132700:G:T | G46V | 0.997 |
| 17:19132706:T:A | I48N | 0.997 |
| 17:19132721:T:A | I53N | 0.997 |
| 17:19138497:G:C | A70P | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1002170357 (17:19151667 C>G,T), RS1003178451 (17:19142185 G>T), RS1003289547 (17:19144023 T>C), RS1003969866 (17:19147468 C>T), RS1004086008 (17:19149160 T>C), RS1005018505 (17:19136833 C>T), RS1005542978 (17:19141613 C>G), RS1006137984 (17:19128810 G>A), RS1006436129 (17:19126556 G>A), RS1010594742 (17:19144081 G>A), RS1010959268 (17:19146359 T>C), RS1011546254 (17:19132960 T>C), RS1012016294 (17:19131963 G>T), RS1012442576 (17:19141874 C>G,T), RS1012803700 (17:19143376 G>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002938_16 | Copper levels | 2.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| jinfukang | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Urethane | decreases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.